Scleroderma study aims to uncover links between mind, body, and mobility
NCT ID NCT07183072
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how biological, psychological, and social factors affect physical performance in people with scleroderma. Researchers will test 50 children and adults using simple tasks like walking, stair climbing, and standing up from a chair. The goal is to find better ways to measure function and improve disease management.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify simple tests to measure physical function in scleroderma patients, helping doctors better manage the disease.
- What could go wrong
- This is a small observational study (50 people) that does not test a treatment, so it won't directly improve symptoms. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONALITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hacettepe University
RECRUITINGÇankaya, Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can skin biopsies unlock new treatments for scleroderma?
- Could a skin patch ease stomach pain in scleroderma?
- Could a painless microneedle pad ease Raynaud's in scleroderma?
- Can a new pill ease the hardening skin of systemic sclerosis?
- A drug after transplant may stop scleroderma from coming back
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.